FDAnews
www.fdanews.com/articles/97001-aveo-announces-successful-completion-of-discovery-agreement-for-novel-cancer-drugs

Aveo Announces Successful Completion of Discovery Agreement for Novel Cancer Drugs

August 9, 2007

Aveo Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, announced it has successfully completed its multi-year collaborative agreement with Merck & Co., Inc., which utilized Aveo’s proprietary cancer models to identify and validate essential tumor maintenance genes which are attractive targets for the development of small molecule oncology agents.
Aveo